Biography and Research Information
OverviewAI-generated summary
Emily Ward Bivens' research portfolio includes work in feminist literary criticism and clinical trial research. Her publications explore themes of gender and narrative representation, as seen in "Destabilizing the Legacies of Eggsplaining: A Feminist Reading of Humpty Dumpty." Concurrently, Bivens has contributed to clinical research, including a Phase I/II trial investigating a therapeutic vaccine for reducing head and neck cancer recurrence. This work involves collaboration with researchers at the University of Arkansas for Medical Sciences, including David W. Ussery, Jennifer L. Faulkner, Yong‐Chen Lu, and Jumin Sunde. Bivens' scholarly output, while currently modest with an h-index of 1 and three publications, indicates engagement in both humanities and health sciences research.
Metrics
- h-index: 1
- Publications: 3
- Citations: 1
Selected Publications
-
A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence (2026)
Collaboration Network
Top Collaborators
Maria Stehle
University of Tennessee at Knoxville (US)
2 shared publications
- Destabilizing the Legacies of Eggsplaining: A Feminist Reading of Humpty Dumpty
- Brambling as research-creation: Tales of <i>the oppositional and</i>
Omar Atiq
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Teresa Evans
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Milan Bilami
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Ginger Brown
Winthrop Rockefeller Foundation
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Jasmine Crane
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Nadia Darwish
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Jennifer L. Faulkner
Winthrop Rockefeller Foundation
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Rangaswamy Govindarajan
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Aaron Johnson
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Alongkorn Kurilung
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Oxana P. Lazarenko
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Yong-Chen William Lu
University of Arkansas for Medical Sciences (US)
1 shared publication
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Keanna Marsh
University of Arkansas for Medical Sciences
1 shared publication
In database
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
M Moreno
University of Arkansas for Medical Sciences (US)
1 shared publication
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
Similar Researchers
Based on overlapping research topics
Andrew A. Taylor
Arkansas Tech University
Cancer Treatment and Pharmacology
Race, History, and American Society
Media Studies and Communication
Milan Bilami
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Head and Neck Cancer Studies
Vaccine Coverage and Hesitancy
Mindy Wilman
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Head and Neck Cancer Studies
Vaccine Coverage and Hesitancy
Aaron Johnson
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Head and Neck Cancer Studies
Vaccine Coverage and Hesitancy
Yong-Chen William Lu
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Head and Neck Cancer Studies
Vaccine Coverage and Hesitancy
Emre Duval
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Head and Neck Cancer Studies
Vaccine Coverage and Hesitancy